Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Prothena Reports Third Quarter 2024 Financial Results and Business Highlights

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Managed Care
Pharmaceutical
Oncology
Mental Health
Hospitals
Clinical Trials
Science
Cardiology
Neurology
Biotechnology
FDA
Health
Other Science
Third Quarter 2024 Financial Results

More Like This

Business Wire logo

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

Business Wire logo

Prothena Reports First Quarter 2024 Financial Results and Business Highlights

Business Wire logo

Prothena Reports First Quarter 2025 Financial Results and Business Highlights

Business Wire logo

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights

Business Wire logo

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

Business Wire logo

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

Business Wire logo

Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs

Business Wire logo

Prothena to Report Third Quarter 2023 Financial Results on November 2

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us